KRAS and cholangiocarcinoma: Furthermore, hotspot KRAS mutations have been shown to occur more frequently in periductal infiltrating-type CCA than in the mass-forming subtype [121], suggesting that the pattern of tumor growth may also be linked to specific molecular profiles.